![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SLNCF market cap is 699.92M. The company's latest EPS is GBP -0.4018 and P/E is -16.18.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 244k | 5.48M | 12.42M | 17.5M | 25.38M |
Operating Income | -22.73M | -32.48M | -45.81M | -48.59M | -49.6M |
Net Income | -19.58M | -32.55M | -39.41M | -40.49M | -43.27M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 46.08M | 85.97M | 96.19M | 107.5M | 93.82M |
Total Liabilities | 25.17M | 76.91M | 87.67M | 85.43M | 76.77M |
Total Equity | 20.91M | 9.06M | 8.53M | 22.07M | 17.05M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | 1.73M | -10.78M | 6.81M | -45.46M | -39.35M |
Investing | -15.02M | 9.62M | 8.68M | -16.54M | 16.43M |
Financing | 5.27M | 15.43M | 30.71M | 43.05M | 25.16M |
Market Cap | 699.92M |
Price to Earnings Ratio | -16.18 |
Price to Sales Ratio | 27.58 |
Price to Cash Ratio | 12.95 |
Price to Book Ratio | 41.05 |
Dividend Yield | - |
Shares Outstanding | 107.68M |
Average Volume (1 week) | 873 |
Average Volume (1 Month) | 653 |
52 Week Change | 664.26% |
52 Week High | 10.90 |
52 Week Low | 0.60 |
Spread (Intraday) | 5.78 (51.65%) |
Company Name | Silence Therapeutics PLC (PK) |
Address |
27 eastcastle street london W1W 8DH |
Website | https://www.silence-therapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions